Friday, Nov 27, 2020
Focus on the big picture

FDA, EU diverge on AstraZeneca COVID-19 vaccine

Reuters, 02 Oct 2020
The FDA has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:
Related Articles